Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Global Health has informed that meeting with the representatives of Investors/Analysts are scheduled with the Management of the Company, as per the details enclosed. No Unpublished Price Sensitive Information is proposed to be shared, thereat.
The above information is a part of company’s filings submitted to BSE.